CYBERDYNE Inc. (CYBQY)
OTCMKTS · Delayed Price · Currency is USD
1.220
-0.029 (-2.32%)
At close: Aug 18, 2025
CYBERDYNE Market Cap
CYBERDYNE has a market cap or net worth of $291.26 million as of August 19, 2025. Its market cap has decreased by -4.34% in one year.
Market Cap
291.26M
Enterprise Value
259.30M
Revenue
29.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.22
Market Cap Chart
Since March 26, 2014, CYBERDYNE's market cap has decreased from 1.02B to 291.26M, a decrease of -71.40%. That is a compound annual growth rate of -10.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 304.11M | 25.07% |
| Dec 30, 2024 | 243.15M | -27.53% |
| Dec 29, 2023 | 335.50M | -31.68% |
| Dec 30, 2022 | 491.04M | -25.76% |
| Dec 30, 2021 | 661.43M | -56.25% |
| Dec 30, 2020 | 1.51B | 34.91% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 614.68M |
| Glass House Brands | 595.63M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 375.77M |
| CytoDyn | 360.07M |